Physician profile
Megan E Downey
NPI 1972699486
$2,178.80
in general payments reported to CMS, 2019-2025
19 companies · $1,167 in 2025
The $1,167 reported for 2025 was more than what 91% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $572 · 2022: $21.34 · 2023: $248 · 2024: $171 · 2025: $1,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $506.16 | 2021-2025 | |
| Abbott Laboratories | $340.88 | 2021-2025 | Cardiomems |
| Biotronik INC. | $239.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $172.46 | 2021-2025 | |
| Novo Nordisk INC | $161.50 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $120.26 | 2021-2024 | Xarelto |
| Pfizer INC. | $111.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.77 | 2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $80.44 | 2025 | Opsynvi |
| Alnylam Pharmaceuticals INC. | $73.82 | 2025 | Onpattro, Amvuttra |
| Scpharmaceuticals INC. | $60.00 | 2025 | |
| Lilly USA, LLC | $42.27 | 2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $35.03 | 2025 | |
| Abiomed | $32.68 | 2025 | |
| Edwards Lifesciences Corporation | $30.72 | 2023 | Inspiris Resilia Aortic Valve |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $23.02 | 2025 | Edarbi |
| E.R. Squibb & Sons, L.L.C. | $22.34 | 2025 | Camzyos |
| Amgen INC. | $14.21 | 2025 | Repatha |
| Vivaquant INC, Dba Rhythm Express | $11.50 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.